Human AMY3R (CTR&RAMP3) (Luc) BHK 21 Reporter Cell Development Service

Cat. No. / Size
Price
Qty
SCBHK-ATF231-2Vials (1Vial X 2)
$15220.00
ETA of in-stock products:2 business days

Product Details

    1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
    2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
    3. Comprehensive application data to support assay development and validation
    4. Full tracible record, stringent quality control and validated cell passage stability
    5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
    6. Global commercial license assistance whenever regulatory filing is required
  • Description

    The Human AMY3R (CTR&RAMP3) (Luc) BHK 21 Reporter Cell was engineered to not only express CREB signaling response element, but also express the human AMY3R generated by co-expressing the full length human calcitonin receptor (CTR) (Uniprot: P30988-2) and the full length human receptor activity-modifying protein 3 (RAMP3) (Uniprot: O60896) added with an mGFP tag, which can drive luciferase expressing systems by amylin receptor (AMYR) agonists or amylin stimulation. In the absence of agonist or amylin, the AMY3R receptor is not activated and luminescence signal is low. In the presence of agonist or amylin, the AMY3R pathway-activated luminescence can be detected in a dose-dependent manner.

  • Application

    • Screen for AMYR agonists that can bind and activate AMY3R.

    AMY3R (CTR&RAMP3) Assay Principles

  • Growth Properties

    Adherent

  • Selection Marker

    Puromycin (2 μg/mL) + Hygromycin B (20 μg/mL) + Zeocin (20 μg/mL)

  • Complete Growth Medium

    DMEM + 10% FBS

  • Freeze Medium

    Serum-free cell cryopreservation medium

  • Quantity

    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

  • Storage

    Frozen in liquid nitrogen.

  • Mycoplasma Testing

    Negative

  • Sterility Testing

    Negative

  • Instructions for Use

    See data sheet for detailed culturing and assay protocol.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Receptor Assay

     AMY3R (CTR&RAMP3) FACS

    Expression analysis of human receptor activity-modifying protein 3 (RAMP3) on Human AMY3R (CTR&RAMP3) (Luc) BHK 21 Reporter Cell by FACS.
    Surface expression of human RAMP3 on Human AMY3R (CTR&RAMP3) (Luc) BHK 21 Reporter Cell was confirmed by detection of mGFP (FITC) using flow cytometry.

    Protocol
  • Application

     AMY3R (CTR&RAMP3) APPLICATION

    Bioactivity analysis of human AMYR agonist (RLU).
    This reporter cell was incubated with serial dilutions of Amylin and human AMYR (Cagrilintide). The EC50 of Amylin was approximately 2.60 nM. The EC50 of Cagrilintide was approximately 0.34 nM.

    Protocol
  •  AMY3R (CTR&RAMP3) APPLICATION

    Bioactivity analysis of human AMYR agonist (FOLD).
    This reporter cell was incubated with serial dilutions of Amylin and human AMYR agonist (Cagrilintide). The max induction fold of Amylin was approximately 15.81. The max induction fold of Cagrilintide was approximately 16.67.

    Protocol
*Please contact us if you are interested in related cell pool service.

Customer Reviews
Writing Reviews

Important Statement

  • Limited Use&License Disclosure

    BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE FOLLOWING TERMS OF LIMITED USE OF THIS CELL LINE PRODUCT.

    1. If the researcher is not willing to accept the terms of limited use of this cell line product, and the product is unused, ACRO will accept return of the unused product.
    2. Researchers may use this product for research use only, no commercial use is allowed. "Commercial use" means any and all uses of this product and derivatives by a party for profit or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research.
    3. This cell line is neither intended for any animal or human therapeutic purposes nor for any direct human in vivo use. You have no right to share, modify, transfer, distribute, sell, sublicense, or otherwise make the cell line available for use to other researchers, laboratories, research institutions, hospitals, universities, or service organizations.
    4. ACROBIOSYSTEMS MAKES NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, EITHER EXPRESSED OR IMPLIED, WITH RESPECT TO THE SUITABILITY OF THE CELL LINE FOR ANY PARTICULAR USE.
    5. ACROBIOSYSTEMS ACCEPTS NO LIABILITY IN CONNECTION WITH THE HANDLING OR USE OF THE CELL LINE.
    6. Modifications of the cell line, transfer to a third party, or commercial use of the cell line may require a separate license and additional fees. Please contact order@acrobiosystems.com for further details.

Recent Advances

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Important Statement